BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1835625)

  • 1. Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line.
    Kano Y; Akutsu M; Kasahara T; Sakamoto S
    Eur J Cancer; 1991; 27(9):1141-5. PubMed ID: 1835625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
    Kano Y; Ohnuma T; Okano T; Holland JF
    Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.
    Kano Y; Sakamoto S; Kasahara T; Akutsu M; Inoue Y; Miura Y
    Leuk Res; 1991; 15(11):1059-66. PubMed ID: 1961009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.
    Akutsu M; Furukawa Y; Tsunoda S; Izumi T; Ohmine K; Kano Y
    Leukemia; 2002 Sep; 16(9):1808-17. PubMed ID: 12200697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical evidence for synergistic combination treatment with methotrexate and 6-mercaptopurine in acute lymphoblastic leukemia.
    Bökkerink JP; Damen FJ; Hulscher MW; Bakker MA; De Abreu RA
    Haematol Blood Transfus; 1990; 33():110-7. PubMed ID: 2323622
    [No Abstract]   [Full Text] [Related]  

  • 6. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
    Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
    Kano Y; Akutsu M; Suzuki K; Yoshida M
    Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro.
    Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y; Furukawa Y
    Jpn J Cancer Res; 2001 Jan; 92(1):74-82. PubMed ID: 11173547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy?
    Balis FM; Jeffries SL; Lange B; Murphy RF; Doherty KM; Arndt CA; Luery N; Poplack DG
    Am J Pediatr Hematol Oncol; 1989; 11(3):324-6. PubMed ID: 2782561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of methotrexate and 6-mercaptopurine on cell growth and clonogenicity of cultured human T-lymphoblasts.
    De Abreu RA; Bökkerink JP; Bakker MA; Hulscher TW; de Vaan GA; de Bruijn CH; Schretlen ED
    Adv Exp Med Biol; 1986; 195 Pt B():129-34. PubMed ID: 3490117
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell line.
    Kano Y; Suzuki K; Akutsu M; Suda K
    Leukemia; 1992 May; 6(5):440-5. PubMed ID: 1593909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular pharmacology and biochemistry of methotrexate and 6-mercaptopurine in childhood acute lymphoblastic leukemia.
    Keuzenkamp-Jansen CW; Bökkerink JP; Trijbels JM; vd Heijden MA; De Abreu RA
    Adv Exp Med Biol; 1994; 370():115-8. PubMed ID: 7660872
    [No Abstract]   [Full Text] [Related]  

  • 14. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
    Nandy P; Periclou AP; Avramis VI
    Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
    van der Werff Ten Bosch J; Suciu S; Thyss A; Bertrand Y; Norton L; Mazingue F; Uyttebroeck A; Lutz P; Robert A; Boutard P; Ferster A; Plouvier E; Maes P; Munzer M; Plantaz D; Dresse MF; Philippet P; Sirvent N; Waterkeyn C; Vilmer E; Philippe N; Otten J
    Leukemia; 2005 May; 19(5):721-6. PubMed ID: 15744348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
    Nygaard U; Toft N; Schmiegelow K
    Clin Pharmacol Ther; 2004 Apr; 75(4):274-81. PubMed ID: 15060506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of "first-pass" metabolism.
    Kato Y; Matsushita T; Uchida H; Egi S; Yokoyama T; Mohri K
    Eur J Clin Pharmacol; 1992; 42(6):619-22. PubMed ID: 1623901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
    Estlin EJ; Lowis SP; Hall AG
    Br J Haematol; 2000 Jul; 110(1):29-40. PubMed ID: 10930977
    [No Abstract]   [Full Text] [Related]  

  • 20. Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance.
    Macdougall LG; McElligott SE; Ross E; Greeff MC; Poole JE
    Ther Drug Monit; 1992 Oct; 14(5):371-5. PubMed ID: 1448843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.